This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns. Background information on Orphan News :: Treatment & Health  -  25 Mar 2008 Checkbiotech.org (press release),...a product approved in the United States for the treatment ofpatients with relapsed or refractory acute promyelocytic leukemia, and CEP-701,an oral small Cephalon gets FDA OK for Treanda  -  Mar 20, 2008 Bizjournals.com,Trisenox is a therapy for a less common type of leukemia known as relapsed, or refractory, acute promyelocytic leukemia. The company bought Trisenox in 2005 Cephalon Gets FDA Nod for Novel CLL Chemotherapy  -  Mar 22, 2008 Genetic Engineering News (press release),Trisenox was sanctioned for the treatment of relapsed or refractory acute promyelocytic leukemia in 2000 and was acquired by the firm from Cell Therapeutics Flow Cytometry and Molecular Genetics for Hematologic Neoplasms  -  Mar 21, 2008 Medscape (subscription)Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood. 1999;94:417-428. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy ...  -  Mar 20, 2008 WELT ONLINE,...a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, and CEP-701, Cephalon's Treanda gets FDA approval  -  Mar 21, 2008 The Money Times,Cephalon, which already has acute Promyelocytic Leukemia drug Trisenox in the market, had total sales of $1.7 billion for 2007. Going bald for good cause  -  Mar 10, 2008 Kenai Peninsula Online,Charlie Yamada, Marcus' mother, said doctors diagnosed her son with promyelocytic leukemia, a rare form that requires a full year of cancer treatment Membrane-anchored growth factor, HB-EGF, on the cell surface ...  -  Feb 25, 2008 Journal of Cell Biology (subscription)...nuclear envelope; ONM, outer nuclear membrane; PLZF, promyelocytic leukemia zinc finger protein; TPA, phorbol ester 12-O-tetradecanoylphorbol-13-acetate. FDA Accepts Treanda New Drug Application for the Treatment of ...  -  Feb 19, 2008 PharmaLive.com (press release),...a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, and CEP-701, TREANDA Significantly Improves Clinical Outcomes in Patients with ...  -  Dec 10, 2007 CNNMoney.com...a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, and CEP-701, Pharmion Presents Clinical Data Demonstrating Significant Survival ...  -  Dec 9, 2007 CNNMoney.com312-II: DNA Methylation Analysis of 807 Genes in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia (Abstract #2122). -- Poster Board No. INNOVIVE Pharmaceuticals Presents Phase I Data on INNO-406 for ...  -  Dec 10, 2007 PR-Inside.com (Pressemitteilung),...for the treatment of chronic myelogenous leukemia, acute promyelocytic leukemia, small cell lung cancer, and acute myelogenous leukemia, respectively. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and ...  -  Dec 3, 2007 Journal of Cell Biology (subscription)Abbreviations used in this paper: ALT, alternative lengthening of telomere; APB, ALT-associated PML body; APL, acute promyelocytic leukemia; DOX, all-trans retinoic acid helps acute promyelocytic leukemia  -  Nov 10, 2007 Food Consumer,...by sue mueller a japanese study showed that all-trans retinoic acid treatment got a 64-year old man with npm-rar-positive apl into remission, innovive initiates phase ii clinical trial of leukemia drug  -  Nov 16, 2007 Trading Markets (press release),...pivotal phase ii clinical trial evaluating oral tamibarotene for the treatment of refractory acute promyelocytic leukemia. this trial will be conducted innovive pharmaceuticals announces third quarter 2007 financial ...  -  Nov 14, 2007 Business Wire (press release),...“we’ve recently opened for enrollment our pivotal phase ii clinical trial for tamibarotene in acute promyelocytic leukemia, and we expect to present updated acute myelogenous leukemia  -  Nov 20, 2007 Journal of American Medical Association (subscription),...which translational medicine has made a difference (highlighting one of translational medicine's "poster child" diseases—acute promyelocytic leukemia), fda orphan drug designation for apl drug  -  Nov 6, 2007 Checkbiotech.org (press release),...tamibarotene in acute promyelocytic leukemia patients who have received prior therapy with atra and arsenic trioxide), the open-label, non-randomized, innovive pharmaceuticals to present at the rodman & renshaw acumen ...  -  Nov 1, 2007 Trading Markets (press release),...inno-406, inno-206, and inno-305, for the treatment of acute promyelocytic leukemia, chronic myelogenous leukemia, small cell lung cancer, the center for outpatient services shows commitment to chemo patients  -  Nov 13, 2007 SBIndependent,...at a yearly physical that smith, who lives in holbrook and has two daughters, was diagnosed with acute promyelocytic leukemia, a rare type of cancer. tamibarotene receives orphan drug designation  -  Nov 5, 2007 Cancer Consultants (press release),...inc. orphan drug designation for their agent tamibarotene for the treatment of acute promyelocytic leukemia (apl). the indication of the designation is noted oncologist samuel waxman authors far-reaching wall street ...  -  Oct 31, 2007 PR-Inside.com (Pressemitteilung),...and now used worldwide, have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (apl), INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug ...  -  Oct 15, 2007 Business Wire (press release),Known as STAR-1 (A Phase II Study of Oral Tamibarotene in Acute Promyelocytic Leukemia Patients who Have Received Prior Therapy with ATRA and Arsenic The New Ways We Fight Cancer  -  Oct 17, 2007 Wall Street JournalIn 1989, a drug removing the abnormal protein causing acute promyelocytic leukemia (APL) was first successfully used. Since then, the cure rate for APL has Orphan News :: Treatment & Health  -  Oct 16, 2007 Checkbiotech.org (press release),Acute promyelocytic leukemia is a subtype of acute myelogenous leukemia, a cancer of the blood and bone marrow. In APL, there is an abnormal accumulation of FDA grants orphan drug designation to Innovive's tamibarotene  -  Oct 17, 2007 Trading Markets (press release),...of adult patients with relapsed or refractory acute promyelocytic leukemia following treatment with all-trans-retinoic acid and arsenic trioxide. INNOVIVE Pharmaceuticals to Present at the BIO InvestorForum  -  Oct 4, 2007 Business Wire (press release),...for the treatment of acute promyelocytic leukemia, chronic myelogenous leukemia, small cell lung cancer, and acute myelogenous leukemia respectively. Cephalon Submits New Drug Application for TREANDA for the ...  -  Sep 21, 2007 CNNMoney.com...a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, and CEP-701, Cephalon Submits Treanda NDA: Orphan Drug For CLL  -  Sep 21, 2007 BioWorld Online,Cephalon's other oncology product, Trisenox (arsenic trioxide), an injectable cleared in the US for relapsed or refractory acute promyelocytic leukemia. Dunbar dairy farmer giving back to community  -  Oct 12, 2007 Connellsville Daily Courier,Pat Wascak was diagnosed with acute promyelocytic leukemia, a cancer of the blood and bone marrow, in March. "There were days I stayed in the hospital and Euroscreen Receives Key US Patent Covering Screening Methods Using ...  -  Sep 27, 2007 Emediawire (press release),The group of Professor Jean-Marie Boeynaems has shown that the activation of the P2Y11 receptor leads to the differentiation of human promyelocytic leukemia Stars come out for fund-raiser  -  Oct 11, 2007 Philadelphia Inquirer,In 2002, Morariu was the WTA comeback player of the year after recovering from acute promyelocytic leukemia. "I understand how important the money is INNOVIVE Pharmaceuticals Acquires Exclusive Rights to Develop and ...  -  10 Sep 2007 Genetic Engineering News (press release),Acute promyelocytic leukemia is a subtype of acute myelogenous leukemia, a cancer of the blood and bone marrow. In APL, there is an abnormal accumulation of Little Britain girl cuts hair for cancer  -  Sep 7, 2007 Kawartha Media Group,Ms Linton says Josie was diagnosed with acute promyelocytic leukemia in November of 2000, when she was just six years old. Ten days after her first chemo FDA Grants Orphan Drug Designation to TREANDA, an Investigational ...  -  Aug 29, 2007 CNNMoney.com...a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia (APL), and CEP-701, INNOVIVE Pharmaceuticals Announces Second Quarter 2007 Financial ...  -  Aug 14, 2007 Genetic Engineering News (press release),..."In the coming months, we expect to initiate a pivotal Phase II clinical trial with Tamibarotene in acute promyelocytic leukemia and we expect to determine Arsenic patent keeps drug for rare cancer out of reach of many  -  Aug 31, 2007 Nature.com (subscription),In the past few decades, some scientists have discovered arsenic's ability to cure acute promyelocytic leukemia (APL), a rare and fatal cancer that strikes Innovive reaches agreement with FDA for leukemia drug trial  -  Aug 6, 2007 Pharmaceutical Business ReviewAcute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML). The SPA is an agreement between Innovive and the FDA on the pivotal Phase Scientists Gain Important Insights Into Acute Promyelocytic Leukemia  -  Jul 11, 2007 Science Daily (press release)Most cases of APL are caused by the expression of the PML/RARA (promyelocytic leukemia/retinoic acid receptor alpha) oncogene. This oncogene is formed by an INNOVIVE Pharmaceuticals Reaches Agreement with FDA on Special ...  -  Aug 3, 2007 Business Wire (press release),The study will be known as STAR-1 (A Phase II Study of Oral Tamibarotene in Acute Promyelocytic Leukemia Patients who Have Received Prior Therapy with ATRA Innovive Pharmaceuticals Reaches Agreement with FDA for ...  -  Aug 6, 2007 FDA news (subscription),Phase II clinical trial to evaluate Tamibarotene, its drug candidate for the treatment of relapsed or refractory acute promyelocytic leukemia (APL). A Voluntary Recall of a Specific Batch of “Vesanoid Capsule,â€? a ...  -  Aug 3, 2007 PharmaLive.com (press release),...today that it has begun a voluntary recall of “Vesanoid® Capsule,â€? a treatment for acute promyelocytic leukemia, that Chugai manufactures and markets. Chugai Recalls Batch of Vesanoid in Japan  -  Aug 6, 2007 FDA news (subscription),Japanese drug company Chugai Pharmaceutical announced that it is voluntarily recalling Vesanoid capsules, a treatment for acute promyelocytic leukemia, Brave Micky beating cancer  -  Jul 14, 2007 Melbourne Herald Sun,Mickayla was six when she was diagnosed with acute promyelocytic leukemia. That was the start of a four-year nightmare for the Prindable family, Roche's Chugai recalls Vesanoid capsules against leukemai ...  -  Aug 3, 2007 Forbes,AG unit Chugai Pharmaceutical Co Ltd announced it is voluntarily recalling Vesanoid capsules used as a treatment for acute promyelocytic leukemia. Cancer Agents Show First-Line Potential  -  Jul 24, 2007 Journal of American Medical Association (subscription),...arsenic trioxide to standard therapy significantly increased overall survival among adults with newly diagnosed acute promyelocytic leukemia (APL). Five New Research Programs to Receive Funding from the Samuel ...  -  Aug 9, 2007 Genetic Engineering News (press release),...have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (APL), which has helped cure 50000 people. More on arsenic anticancer drugs  -  Jul 16, 2007 ScienceBlogsTrisenox, approved in the US in 2000 for treatment of acute promyelocytic leukemia (APL), is also being investigated for other hematologic malignancies. Arsenic treats uncommon type of leukemia  -  Jun 20, 2007 News 8 Austin,Acute Promyelocytic Leukemia is an uncommon type of acute myeloid leukemia. It only makes up about 10 percent of all types of leukemia, with about 1500 Barr Gets Generic Vesanoid Approval  -  Jun 22, 2007 Forbes,The approval covers the 10-milligram capsule, aimed at treating acute promyelocytic leukemia, a type of blood and bone marrow cancer. Arsenic Treats Leukemia  -  Jun 21, 2007 WTVF,It's part of the plan to keep her acute promyelocytic leukemia, or APL, in remission. "Everyone that heard it was like, ‘oh that's, you know, this is not, One-time Maverick faces cancer with 'attaboy' spirit he showed on ...  -  Jun 14, 2007 SI.comThe culprit: acute promyelocytic leukemia, which the American Cancer Society says accounts for about 3 percent of leukemia cases. The cancer was declared in Arsenic Treats Leukemia  -  Jun 18, 2007 ABC7Chicago.com,June 18, 2007 - Acute promyelocytic leukemia (APL) is an uncommon type of acute myeloid leukemia. It only makes up about 10 percent of all types of leukemia Exploring The Mechanisms Of Leukemia EHA Congress 2007  -  Jun 14, 2007 Medical News Today (press release),..."We not only detected new subgroups but also a specific micro-RNA signature that indicates acute promyelocytic leukemia," Dr. Bullinger noted. China’s New Minister of Health  -  Jun 29, 2007 World Health Care Blog,Chen won international acclaim for his achievements in the clinical and molecular study of the treatment of acute promyelocytic leukemia. Relay for Life: Remembering the longest day of his life  -  Jun 13, 2007 Brighton Standard-Blade,The bone-marrow test confirmed the diagnosis – acute promyelocytic leukemia – a rare and previously hard to treat form of leukemia. China welcomes more non-communist voice in politics  -  Jun 29, 2007 Xinhua,Chen, a French-trained scientist, was noted for his achievements in the clinical and molecular study of the treatment of acute promyelocytic leukemia. Tretinoin Capsules Approved  -  Jun 25, 2007 Facts and Comparisons,The FDA has approved Barr Laboratories’ tretinoin 10 mg capsules to induce remission in certain patients with acute promyelocytic leukemia (APL), Non-Toxic Treatment for Lung Cancer Presented at International ...  -  Jun 29, 2007 Web Services Journal,...normal cells has been proven clinically as a viable treatment for cancer and is used in the treatment of patients with Acute Promyelocytic Leukemia. INNOVIVE Pharmaceuticals Closes $15 Million Equity Financing  -  Apr 25, 2007 American Venture Magazine (press release),We also plan to initiate a Phase II trial with INNO-206 in small cell lung cancer and a pivotal trial with Tamibarotene for acute promyelocytic leukemia." 'People have carried us through this  -  Apr 5, 2007 Lebanon Western Star,Hodges, who was diagnosed with acute promyelocytic leukemia March 1, also is 25 weeks pregnant with her first child, a girl. Translocation kidney cancer after chemotherapy in childhood  -  Apr 22, 2007 News-Medical.net,The indications varied and including acute promyelocytic leukemia, acute myeloid leukemia, bilateral Wilms' tumor, systemic lupus erythematosus, Research Supported by Samuel Waxman Cancer Research Foundation ...  -  Apr 16, 2007 Genetic Engineering News (press release),...results of research describing a new mode of action of arsenite (a form of the metal arsenic) in the treatment of acute promyelocytic leukemia (APL). New Approaches To Make Bone Marrow Transplantation Safer And More ...  -  Apr 24, 2007 eMaxHealth.com,...centers in the country to use a revolutionary new therapy, arsenic trioxide to treat a form of leukemia known as acute promyelocytic leukemia (APL). INNOVIVE Pharmaceuticals Announces Preclinical Data from INNO-206 ...  -  Apr 19, 2007 PipelineReview.com (press release),...for the treatment of chronic myelogenous leukemia, acute promyelocytic leukemia, small cell lung cancer, and acute myelogenous leukemia, respectively. Innovive Pharmaceuticals to Present at the CIBC World Markets ...  -  Apr 11, 2007 PharmaLive.com (press release),...for the treatment of acute promyelocytic leukemia, chronic myelogenous leukemia, small cell lung cancer, and acute myelogenous leukemia respectively. Samuel Waxman Cancer Research Foundation Announces Press Conference  -  Apr 19, 2007 Business Wire (press release),...have proven the effectiveness of non-toxic differentiation in the treatment of acute promyelocytic leukemia (APL), which has helped cure 50000 people. Cell Therapeutics settles law suit with Government  -  Apr 18, 2007 News-Medical.net,...stated, "We were proud to introduce an important and potentially life-saving treatment for patients with relapsed Acute Promyelocytic Leukemia (APL) and Arsenic Compound Effective In Treating Rare Leukemia  -  Feb 19, 2007 Medical News Today (press release),Patients all had newly-diagnosed acute promyelocytic leukemia, or APL, and participated in a multi-year national phase III clinical study. Innovive Pharmaceuticals Appoints Angelo De Caro to Its Board of ...  -  Feb 16, 2007 PharmaLive.com (press release),...for the treatment of acute promyelocytic leukemia, chronic myelogenous leukemia, small cell lung cancer, and acute myelogenous leukemia, respectively. Recipients selected for the Leukemia & Lymphoma Society's Spirit ...  -  Feb 1, 2007 TexasGigs,Having been healthy all her life, in 2004 Christine was diagnosed with Acute Promyelocytic Leukemia (APL), a rare type of leukemia. Dartmouth Researchers Find That Arsenic Triggers Unique Mechanism ...  -  Jan 10, 2007 Medical News Today (press release),...researchers have identified a new way that arsenite, a form of arsenic, acts in treating a rare cancer known as APL, or acute promyelocytic leukemia. In one carcinogen, DMS researchers find a cancer cure  -  Jan 9, 2007 The Dartmouth,...new way by which arsenite, a form of arsenic, can treat acute promyelocytic leukemia by destroying abnormal proteins present within the afflicted cells. INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug ...  -  Jan 8, 2007 PipelineReview.com (press release),In addition to the recently acquired Tamibarotene for acute promyelocytic leukemia, the company has three drug programs in clinical development, INNO-406, Palytoxin: exploiting a novel skin tumor promoter to explore ...  -  Jan 11, 2007 AJP - Cell Physiology (subscription)...that included irritation of mouse ear, induction of ornithine decarboxylase in mouse skin, and adhesion of human promyelocytic leukemia (HL-60) cells. People & Events  -  Dec 28, 2006 Visayan Daily Star,Nine-year-old James Huerva of San Esteban Village, Barangay Lag-asan, Bago City who has been diagnosed to have acute promyelocytic leukemia, Search the web for more resources on   Web health.mongabay.com Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com Disclaimer: Contact a physician with regard to health concerns. Email requests for further health information will be discarded. The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site. Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links. COPYRIGHT 2006 MONGABAY.COM